Breaking: HeartWare wins FDA nod for bridge-to-transplant heart pump

November 20, 2012 by MassDevice staff

HeartWare wins premarket approval for its flagship implantable left ventricular assist device as a bridge to transplant for heart failure patients.

HeartWare International logo

Framingham, Mass.-based cardiac device maker HeartWare International (NSDQ:HTWR) won FDA premarket approval for its HeartWare ventricular assist system as a bridge to heart transplantation.

The HeartWare system includes an implantable pump, external driver and power source that can be used either inside or outside of hospitals, the FDA noted.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.